elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Cystic fibrosis
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Cystic fibrosis
RIS
0.003
(Research Intensity Score)
Papers
403
Top papers
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
2019 · 2146 citations
Cystic fibrosis
2021 · 679 citations
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial
2021 · 396 citations
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
2019 · 1386 citations
Non–Cystic Fibrosis Bronchiectasis in Adults
2025 · 39 citations
Newest papers
Impact of CFTR modulator concentrations on clinical response in cystic fibrosis
2026 · 4 citations
Bacterial EVs contain small RNAs and transfer RNAs that regulate inflammation in lung infections
2026 · 3 citations
Automated Ultrashort Echo Time ( UTE ) MRI Low Signal Volume Analysis in Stable Pediatric Cystic Fibrosis and After Elexacaftor/Tezacaftor/Ivacaftor Therapy
2026 · 1 citations
Non–Cystic Fibrosis Bronchiectasis in Adults
2025 · 39 citations
Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment
2025 · 32 citations
A sample from the 100 top papers behind Cystic fibrosis.
Create a free account to browse them all →
Cystic fibrosis's history
Research intensity over time
Explore Cystic fibrosis's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Cystic fibrosis's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link